Goldman Sachs Downgrades Gentex to Sell, Lowers Price Target to $20

Goldman Sachs analyst Mark Delaney has downgraded Gentex (NASDAQ: GNTX) from Neutral to Sell. The price target for the stock has been reduced from $23 to $20.